Locally Rooted, Globally Scaled.
Backing visionary founders who blend local insights with global potential.
Fern Capital is a $25 million venture fund investing in the $1trillion+ Women’s Health market—one of the fastest-growing yet most underfunded sectors in healthcare. Although women make up 51% of the global population and drive 80% of healthcare spending, less than 4% of R&D funding is allocated to women's health. This gap represents not only a massive opportunity for innovation but a pressing call to action.
We’re here to change that.
Fern Capital invests transnationally in early-stage, high-growth startups across the UK, Europe, and Africa—regions where mobile health adoption reaches 75% and Europe’s AI-powered healthcare market is projected to hit $80B by 2030. Our strategy unlocks differentiated deal flow in high-potential but undercapitalized markets, harnessing Africa’s digital-first health systems and Europe’s cutting-edge research and development.
This is more than a market opportunity. It’s a responsibility—to bridge ecosystems, fund inclusive solutions, and catalyze innovation where it’s needed most. Women’s health is not just an impact play—it’s a global, scalable investment frontier.
We’re not just investing in markets.
We’re investing in the future of care.
We're not just investing to extend lives.
We're investing to extend the healthy years of life.
Fern Capital is led by Co Founders & General Partners, Dr. Afua Basoah and Dr. Abigail Osei-Kumi—two seasoned leaders with deep academic roots and complementary expertise across healthcare, finance, and impact investing. Backed by a world-class Advisory Council of experts in digital health, AI, women’s health, and entrepreneurship, Fern is uniquely positioned to identify, scale, and exit the next generation of transformative ventures.
$25million Debut Fund ('Dignity Fund I') providing seed tickets of $250k - $1million for early stage ventures.
Scientifically backed, clinically validated, tech-enabled personalised solutions that predict, diagnose and/or manage health challenges that disproportionally affect women.
While we all seek unicorns, we believe zebras are just as valuable — profitable, resilient ventures built to endure and create lasting impact.
Visionary founders based in UK, Europe, Nigeria, Kenya, South Africa & Egypt developing scalable and accessible solutions for women in both Global North & South markets.